More than 175 biotechs adopt Veeva Basics for drug development ops

Go back to More than 175 biotechs adopt Veeva Basics for drug development ops

Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development

October 7, 2026 7:03 AM EDT

More than 175 biotechs use pre-configured applications to streamline operations

PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are launching pre-configured and pre-validated Veeva Basics applications in weeks, adding... More